Meet the ‘most loved’ healthcare companies

A handful of healthcare companies have made it onto Newsweek’s “Most Loved Workplaces” list. 

The list, produced in partnership with the Best Practice Institute, ranks 100 small, medium and large companies based on how employees feel about their companies. The Best Practice Institute is a leadership development center and think tank that developed the research underpinning the rankings in collaboration with the University of Pittsburgh.

The list comes at a critical time for the healthcare industry, as the stressors and demands of the COVID-19 pandemic have led a significant portion of workers to consider leaving their careers after the pandemic. 

In addition, healthcare workplaces have grappled with mandating COVID-19 vaccines to their employees, causing further setbacks in employment. Overall, the labor market is tight, with millions of Americans quitting their jobs and finding new roles over the past few months.

Despite these challenges, eight healthcare companies made the list. Here are the companies that were named and their overall rank out of 100:

  • Boston Scientific–14
  • Cerner–32
  • ChenMed–36
  • Fresenius Medical Care–42
  • Horizon Therapeutics Pharmaceuticals–38
  • Eversana Pharmaceuticals–54
  • Nomad Health Hospital and Health Care–72
  • Incyte Pharmaceuticals–77

Newsweek ranked the companies based on several criteria, including management style, altruism, career-building, collaboration and transparency.

"A Most Loved Workplace is focused squarely on the degree to which employees have a positive feeling about their employer," said Louis Carter, CEO of the Best Practice Institute. In other words: "high emotional connection or love for" their place of employment.

See the full list here.

 

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.